2024-05-29 REL RCSB RCSB RCSB 2020-04-11 2021-02-17 2021-02-17 2024-05-29 Structure of human TRPA1 in complex with inhibitor GDC-0334 Rohou A Rouge L Arthur CP TRPA1, channel, inhibitor, antagonist, MEMBRANE PROTEIN, MEMBRANE PROTEIN-Inhibitor complex Balestrini A Joseph V Dourado M Reese RM Shields SD Rouge L Bravo DD Chernov-Rogan T Austin CD Chen H Wang L Villemure E Shore DGM Verma VA Hu B Chen Y Leong L Bjornson C Hotzel K Gogineni A Lee WP Suto E Wu X Liu J Zhang J Gandham V Wang J Payandeh J Ciferri C Estevez A Arthur CP Kortmann J Wong RL Heredia JE Doerr J Jung M Vander Heiden JA Roose-Girma M Tam L Barck KH Carano RAD Ding HT Brillantes B Tam C Yang X Gao SS Ly JQ Liu L Chen L Liederer BM Lin JH Magnuson S Chen J Hackos DH Elstrott J Rohou A Safina BS Volgraf M Bauer RN Riol-Blanco L A TRPA1 inhibitor suppresses neurogenic inflammation and airway contraction for asthma treatment. J.Exp.Med. US 218 2021 33620419 doi:10.1084/jem.20201637 1540-9538 0774 JEMEAV 6wj5 FULLOVERLAP TRPA1 bound by inhibitor GDC-0334 TRPA1 bound by inhibitor GDC-0334 0 1 Homo sapiens Transient receptor potential cation channel subfamily A member 1 Homo sapiens 0.072622125 4 Spodoptera frugiperda LEVO SPLHFAASYGRINTCQRLLQDISDTRLLNEGDLHGMTPLHLAAKNGHDKVVQLLLKKGALFLSDHNGWTALHHASMGGYT QTMKVILDTNLKCTDRLDEDGNTALHFAAREGHAKAVALLLSHNADIVLNKQQASFLHLALHNKRKEVVLTIIRSKRWDE CLKIFSHNSPGNKCPITEMIEYLPECMKVLLDFCMLHSTEDKSCRDYYIEYNFKYLQCPLEFTKKTPTQDVIYEPLTALN AMVQNNRIELLNHPVCKEYLLMKWLAYGFRAHMMNLGSYCLGLIPMTILVVNIKPGMAFNSTGIINETSDHSEILDTTNS YLIKTCMILVFLSSIFGYCKEAGQIFQQKRNYFMDISNVLEWIIYTTGIIFVLPLFVEIPAHLQWQCGAIAVYFYWMNFL LYLQRFENCGIFIVMLEVILKTLLRSTVVFIFLLLAFGLSFYILLNLQDPFSSPLLSIIQTFSMMLGDINYRESFLEPYL RNELAHPVLSFAQLVSFTIFVPIVLMNLLIGLAVGDIADVQKHASLKRIAMQVELHTSLEKKLPLWFLRKVDQKSTIVYP NKPRSGGMLFHIFCFLFCTGEIRQEIPNADKSLEMEILKQKYRLKDLTFLLEKQHELIKLIIQKMEIISET O75762 (4R,5S)-4-fluoro-1-[(4-fluorophenyl)sulfonyl]-5-methyl-N-({5-(trifluoromethyl)-2-[2-(trifluoromethyl)pyrimidin-5-yl]pyridin-4-yl}methyl)-L-prolinamide 0.0006094919999999999 4 LXY singleParticle particle 0.33 8.199999999999999 25.0 Tris 150.0 NaCl NaCl 0.5 TCEP 1.0 Ins6P C-flat-2/1 COPPER CARBON HOLEY GLOW DISCHARGE AIR 0.067
Grid was gold-coated. Glow discharge using GloQube, negative polarity.
 ETHANE 100 277 FEI VITROBOT MARK IV
2 x 4s blot time.
FEI TITAN KRIOS FLOOD BEAM BRIGHT FIELD FIELD EMISSION GUN 300 70.0 2.7 130000.0 FEI TITAN KRIOS AUTOGRID HOLDER NITROGEN GIF Bioquantum 20 GATAN K2 QUANTUM (4k x 4k) COUNTING 1-40 1 10.0 47.5 1 4114800
15,630 movies were selected because of the quality of their CTF fits. 4,114,800 coordinates were selected, leading to 466,632 particles which clustered into high-quality 2D class averages
 1 C4 FOURIER SPACE 3.6 FSC 0.143 CUT-OFF cisTEM
Data at spatial frequencies higher than 1/4.8 A-1 were not used during any part of the refinement.
58836 RANDOM ASSIGNMENT cisTEM OTHER cisTEM 5 cisTEM emd_21688.map.gz 1 IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) 300 300 300 0 0 0 300 300 300 314.1 314.1 314.1 90.0 90.0 90.0 X Y Z -0.558879 0.999257 0.007330487 0.03634888 1.047 1.047 1.047 0.1 AUTHOR Main map, used for making figures. Sharpened, FOM-filtered, unmasked. 3J9P PDB experimental model AB INITIO MODEL
CCG MOE was used for refinement after Phenix real-space refinement.
REAL